What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Immune system
Jean-Paul Soulillou mostly deals with Immunology, Transplantation, Kidney transplantation, Immunosuppression and Internal medicine.
His studies link Cytotoxic T cell with Immunology.
His Transplantation research incorporates themes from In vitro, Kidney, Kidney disease and Renal function.
His study in Kidney transplantation is interdisciplinary in nature, drawing from both Intensive care medicine, Microarray, Peripheral blood mononuclear cell, Gene signature and Biomarker.
His study explores the link between Immunosuppression and topics such as Gastroenterology that cross with problems in Randomized controlled trial, Basiliximab, Randomization and Tolerability.
Interleukin 6 and Leukemia inhibitory factor is closely connected to Endocrinology in his research, which is encompassed under the umbrella topic of Internal medicine.
His most cited work include:
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients (668 citations)
- Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens (604 citations)
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans (439 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Transplantation, Antibody, Kidney transplantation and Kidney.
He regularly ties together related areas like Cytotoxic T cell in his Immunology studies.
Jean-Paul Soulillou has included themes like Immunosuppression and Kidney disease in his Transplantation study.
His research in Antibody focuses on subjects like Molecular biology, which are connected to Endothelial stem cell and Cytokine.
His research in Kidney transplantation intersects with topics in Biomarker, Immune tolerance, Bioinformatics and Intensive care medicine.
The various areas that Jean-Paul Soulillou examines in his Kidney study include Urinary system and Pathology.
He most often published in these fields:
- Immunology (58.49%)
- Transplantation (46.12%)
- Antibody (23.27%)
What were the highlights of his more recent work (between 2011-2021)?
- Immunology (58.49%)
- Transplantation (46.12%)
- Antibody (23.27%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Transplantation, Antibody, Kidney transplantation and Immunosuppression.
Jean-Paul Soulillou has researched Immunology in several fields, including Phenotype and Kidney.
His Transplantation study results in a more complete grasp of Internal medicine.
His Antibody study incorporates themes from Molecular biology and Human leukocyte antigen, Antigen.
His research in Kidney transplantation intersects with topics in Biomarker, Isoantibodies, Bioinformatics and Gene expression profiling.
His work deals with themes such as Transplant rejection and FOXP3, which intersect with Immunosuppression.
Between 2011 and 2021, his most popular works were:
- Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. (167 citations)
- Unique B cell differentiation profile in tolerant kidney transplant patients. (108 citations)
- Unique B cell differentiation profile in tolerant kidney transplant patients. (108 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Immune system
His primary areas of investigation include Immunology, Transplantation, T cell, Kidney transplantation and Antibody.
Jean-Paul Soulillou has included themes like Peripheral blood mononuclear cell and Xenotransplantation in his Immunology study.
His research investigates the link between Transplantation and topics such as Immunosuppression that cross with problems in Glucocorticoid-Induced TNFR-Related Protein.
His T cell study combines topics from a wide range of disciplines, such as Humanized mouse, Systemic inflammation and Ulcerative colitis.
Jean-Paul Soulillou works mostly in the field of Kidney transplantation, limiting it down to concerns involving Biomarker and, occasionally, Personalized medicine, Gene signature, Meta-analysis, Immune tolerance and Transcriptome.
His Antibody research includes themes of Pharmacokinetics, Pharmacodynamics, Antagonist and Potency.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
